购物车
您的购物车当前为空
Multi-target kinase-IN-5 (Compound 23) 是一种具有口服效果的ERK1/2抑制剂 (IC50值分别为 3.04 nM 和 1.57 nM)。它显著地抑制癌细胞的增殖、迁移以及侵袭,并诱导细胞凋亡 (apoptosis) 和细胞周期阻滞。Multi-target kinase-IN-5 通过抑制 ERK1/2 的磷酸化,降低其下游底物 RSK 的活性,从而发挥抗肿瘤作用。Multi-target kinase-IN-5 适用于癌症研究。
Multi-target kinase-IN-5 (Compound 23) 是一种具有口服效果的ERK1/2抑制剂 (IC50值分别为 3.04 nM 和 1.57 nM)。它显著地抑制癌细胞的增殖、迁移以及侵袭,并诱导细胞凋亡 (apoptosis) 和细胞周期阻滞。Multi-target kinase-IN-5 通过抑制 ERK1/2 的磷酸化,降低其下游底物 RSK 的活性,从而发挥抗肿瘤作用。Multi-target kinase-IN-5 适用于癌症研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | Multi-target kinase-IN-5 (Compound 23) is an orally active ERK1/2 inhibitor with IC50 values of 3.04 nM and 1.57 nM, respectively. It notably suppresses cancer cell proliferation, migration, and invasion, while inducing apoptosis and cell cycle arrest. By inhibiting the phosphorylation of ERK1/2 and downregulating the activity of its downstream substrate RSK, Multi-target kinase-IN-5 exhibits antitumor effects. This compound can be utilized in cancer research. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.(实际储存温度请以该批次产品标识为准) |
对于不同动物的给药剂量换算,您也可以参考 更多